Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cumulus Media A | CMLS | May 20, 2024 | 2.98 | -5.40 |
Curevac N.V. | CVAC | May 20, 2024 | 3.40 | -2.58 |
CuriosityStream | CURI | May 20, 2024 | 1.03 | -0.96 |
Curis | CRIS | May 20, 2024 | 10.52 | -10.85 |
Curtiss-Wright | CW | May 20, 2024 | 279.39 | +0.42 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | May 20, 2024 | 42.38 | +0.28 |
Cushman & Wakefield | CWK | May 20, 2024 | 11.45 | -2.30 |
Custom Truck One Source | CTOS | May 20, 2024 | 4.74 | -1.86 |
Customers Bancorp | CUBI | May 20, 2024 | 47.74 | -2.23 |
Customers Bancorp E Pref | CUBI-E | May 20, 2024 | 26.00 | +0.39 |
Customers Bancorp F Pref | CUBI-F | May 20, 2024 | 25.53 | +0.05 |
Cutera | CUTR | May 20, 2024 | 2.26 | +1.80 |
CVB Financial | CVBF | May 20, 2024 | 17.20 | -1.32 |
CVD Equipment | CVV | May 20, 2024 | 4.25 | -3.39 |
CVR Energy | CVI | May 20, 2024 | 29.47 | -0.44 |
Cvr Partners LP Unit | UAN | May 20, 2024 | 86.96 | +1.68 |
CVRx | CVRX | May 20, 2024 | 8.28 | -0.12 |
CVS Health | CVS | May 20, 2024 | 57.40 | -0.49 |
CXApp A | CXAI | May 20, 2024 | 3.26 | +6.54 |
CyberArk Software | CYBR | May 20, 2024 | 249.70 | +1.37 |
Cybin | CYBN | May 20, 2024 | 0.35 | +0.29 |
Cyclacel Pharmaceuticals | CYCC | May 20, 2024 | 2.18 | -4.80 |
Cyclacel Pharmaceuticals Pref | CYCCP | May 20, 2024 | 6.99 | +4.33 |
Cyclerion Therapeutics | CYCN | May 20, 2024 | 2.80 | -1.82 |
Cyclo Therapeutics | CYTH | May 20, 2024 | 1.42 | +1.43 |
Cyngn | CYN | May 20, 2024 | 0.13 | +12.76 |
Cytek Biosciences | CTKB | May 20, 2024 | 5.96 | -2.30 |
Cytokinetics | CYTK | May 20, 2024 | 60.60 | +1.80 |
Cytomed Therapeutics | GDTC | May 20, 2024 | 2.03 | -4.25 |
CytomX Therapeutics | CTMX | May 20, 2024 | 1.92 | +1.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.